These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6445869)

  • 21. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
    Schlegel PG; Vaysburd M; Chen Y; Butcher EC; Chao NJ
    J Immunol; 1995 Oct; 155(8):3856-65. PubMed ID: 7561092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
    J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active suppression of in vitro reactivity of spleen cells after BCG treatment.
    Orbach-Arbouys S; Poupon MF
    Immunology; 1978 Mar; 34(3):431-7. PubMed ID: 305890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction and suppression of graft-versus-host reactivity in B6.C-H-2 mutant mice.
    Molendijk A; van Gurp RJ; van Oudenaren A; Benner R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2698-9. PubMed ID: 2978897
    [No Abstract]   [Full Text] [Related]  

  • 28. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA; Moedder E; MacDonald HR; Engers HD
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
    Krenger W; Snyder K; Smith S; Ferrara JL
    Transplantation; 1994 Dec; 58(11):1251-7. PubMed ID: 7992370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in thymus and spleen cell populations and immune reactivity during syngeneic pregnancy and lactation.
    Gambel PI; Cleland AW; Ferguson FG
    J Clin Lab Immunol; 1980 Mar; 3(2):115-9. PubMed ID: 6451708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.
    Schultz KR; Paquet J; Bader S; HayGlass KT
    Bone Marrow Transplant; 1995 Aug; 16(2):289-95. PubMed ID: 7581150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differentiation of cytotoxic T cells in vitro. II. Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Lyt 2+ cells but not Lyt 1+ cells.
    Okada M; Henney CS
    J Immunol; 1980 Jul; 125(1):300-7. PubMed ID: 6445920
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
    Durakovic N; Radojcic V; Powell J; Luznik L
    Transplantation; 2007 Mar; 83(5):631-40. PubMed ID: 17353785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The restoration of suppressed T cell activities induced by 7,12-dimethylbenz[a]anthracene with an anti-tumor immunomodulator, BCG-cell wall skeleton.
    Yamashita U; Ikegami R; Hamaoka T
    Gan; 1982 Oct; 73(5):783-9. PubMed ID: 6219910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Further qualitative and quantitative studies on the inhibition of in vivo T-cell reactions by drugs].
    Schmassmann E; Alföldy P; Lemmel EM
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1132-5. PubMed ID: 77098
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
    Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
    J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.